According to previous studies, GLA can inhibit epithelial-mesenchymal transition in osteosarcoma by restraining TGF-β1/Smad2/3 signal transduction pathway, so as to achieve the effect of treating osteosarcoma [14]. Here, SMAD2 is linked to osteosarcoma.